Author:
Brawek B.,Löffler M.,Dooley D. J.,Weyerbrock A.,Feuerstein T. J.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology,General Medicine
Reference29 articles.
1. Bandelow B, Wedekind D, Leon T (2007) Pregabalin for the treatment of generalized anxiety disorder: a novel pharmacologic intervention. Expert Rev Neurother 7:769–781
2. Bayer K, Ahmadi S, Zeilhofer HU (2004) Gabapentin may inhibit synaptic transmission in the mouse spinal cord dorsal horn through a preferential block of P/Q-type Ca2+ channels. Neuropharmacology 46:743–749
3. Belliotti T, Ekhato IV, Capiris T, Kinsora J, Vartanian MG, Field M, Meltzer LT, Heffner T, Schwarz JB, Taylor CP, Thorpe A, Wise L, Su T-Z, Weber ML, Wustrow DJ (2005) Structure–activity relationships of pregabalin and analogs that target the alpha2-delta protein. J Med Chem 48:2294–2307
4. Bian F, Li Z, Offord JD, Davis MD, McCormick JA, Taylor CP, Walker LC (2006) Calcium channel alpha2-delta type 1 subunit is the major binding protein for pregabalin in neocortex, hippocampus, amygdale, and spinal cord: an ex vivo audioradiographic study in alpha2-delta type 1 genetically modified mice. Brain Res 1075:68–80
5. Brawek B, Donovan CM, Löffler M, Dooley DJ, Weyerbrock A, Feuerstein TJ (2007) Gapapentin and pregabalin modulate K+-evoked [3H]-neurotransmitter release from discrete rat CNS regions and human neocortex. Naunyn Schmiedebergs Arch Pharmacol 375(Suppl 1):55
Cited by
32 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献